RHODES PHARMS FDA Approval NDA 019891

NDA 019891

RHODES PHARMS

FDA Drug Application

Application #019891

Documents

Label2006-06-12
Letter2006-06-12
Letter2016-12-20
Label2016-12-21
Label2018-09-24
Label2018-09-24
Letter2018-09-28
Letter2018-09-28
Label2019-10-08
Medication Guide2019-10-08
Letter2019-10-08
Letter2021-03-05
Label2021-03-05
Medication Guide2021-03-05

Application Sponsors

NDA 019891RHODES PHARMS

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL5MG/5ML1DILAUDIDHYDROMORPHONE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1992-12-07STANDARD
LABELING; LabelingSUPPL2AP2003-03-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1999-11-24STANDARD
LABELING; LabelingSUPPL4AP2001-08-22STANDARD
LABELING; LabelingSUPPL8AP2006-06-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP2013-11-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2015-02-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2015-03-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2016-02-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL22AP2016-02-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2016-02-05STANDARD
LABELING; LabelingSUPPL24AP2016-12-16STANDARD
REMS; REMSSUPPL26AP2018-09-18N/A
LABELING; LabelingSUPPL27AP2018-09-18STANDARD
LABELING; LabelingSUPPL28AP2019-10-07STANDARD
LABELING; LabelingSUPPL29AP2021-03-04STANDARD

Submissions Property Types

SUPPL3Null0
SUPPL16Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null15
SUPPL26Null7
SUPPL27Null15
SUPPL28Null6
SUPPL29Null6

TE Codes

001PrescriptionAA

CDER Filings

RHODES PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19891
            [companyName] => RHODES PHARMS
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/019891s028,019892s035lbl.pdf#page=28"]
            [products] => [{"drugName":"DILAUDID","activeIngredients":"HYDROMORPHONE HYDROCHLORIDE","strength":"5MG\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"10\/07\/2019","submission":"SUPPL-28","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/019891s028,019892s035lbl.pdf\"}]","notes":""},{"actionDate":"10\/07\/2019","submission":"SUPPL-28","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/019891s028,019892s035lbl.pdf\"}]","notes":""},{"actionDate":"09\/18\/2018","submission":"SUPPL-27","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/019891s026s027,019892s033s034lbl.pdf\"}]","notes":""},{"actionDate":"09\/18\/2018","submission":"SUPPL-26","supplementCategories":"REMS - PROPOSAL - D-N-A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/019891s026s027,019892s033s034lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-24","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/019891s024,019892s029lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-24","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/019891s024,019892s029lbl.pdf\"}]","notes":""},{"actionDate":"06\/12\/2006","submission":"SUPPL-8","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/019892s009,019891s008lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"DILAUDID","submission":"HYDROMORPHONE HYDROCHLORIDE","actionType":"5MG\/5ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-10-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.